The peroxisome proliferators WY-14,643 and methylclofenapate induce hepatocyte ploidy alterations and ploidy-specific DNA synthesis in F344 rats

Toxicology and Applied Pharmacology

Volumn 138, Issue 2, 1996, Pages 317-323

  Miller, Richard T ^a   Shah, Rekha S ^a   Cattley, Russell C ^a   Popp, James A ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLCLOFENAPATE; PEROXISOME PROLIFERATOR; PIRINIXIC ACID; BROXURIDINE; PYRIMIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; LIVER CELL; MALE; NONHUMAN; PLOIDY; POLYPLOIDY; RAT; ANIMAL; CELL CULTURE; DNA REPLICATION; DRUG EFFECT; FISCHER 344 RAT; LIVER; METABOLISM; MICROBODY; ORGAN SIZE;

ANIMALIA; RODENTIA; ZEA MAYS;

ANIMALS; BROMODEOXYURIDINE; CELLS, CULTURED; CLOFENAPATE; DNA REPLICATION; LIVER; MALE; MICROBODIES; ORGAN SIZE; PLOIDIES; PYRIMIDINES; RATS; RATS, INBRED F344;

EID: 0030153488     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0130     Document Type: Article

References (23)

1. Bybee, A., Styles, J. A., Beck, S. L., and Blackburn, D. (1990). Mitosis and histopathology in rat liver during methylclofenapate-induced hyperplasia. Cancer Lett. 52, 95-100.
2. Carriere, R. (1969). The growth of liver parenchymal nuclei and its endocrine regulation. Int. Rev. Cytol. 25, 201-277.
3. Conolly, R. B., and Kimbell, J. S. (1994). Computer simulation of cell growth governed by stochastic processes: Application to clonal growth cancer models. Toxicol. Appl. Pharmacol. 124, 284-295.
4. Marsman, D. S., Cattley, R. C., Conway, J. G., and Popp, J. A. (1988). Relationship of hepatic peroxisome proliferation and replicative DNA synthesis of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (WY-14,643) in rats. Cancer Res. 48, 6739-6744.
5. Melchiorri, C., Chieco, P., Zedda, A. I., Coni, P., Ledda-Columbano, G. M., and Columbano, A. (1993). Ploidy and nuclearity of rat hepatocytes after compensatory regeneration or mitogen induced liver growth. Carcinogenesis 14, 1825-1830.
6. Michalopoulos, G. K., Eckl, P. M., Cruise, J. L., Novicki, D. L., and Jirtle, R. L. (1987). Mechanisms of rodent liver carcinogenesis. Toxicol. Ind. Health 3, 119-127.
7. Moolgavkar, S. H., and Luebeck, E. G. (1992). Interpretation of labeling indices in the presence of cell death. Carcinogenesis 13, 1007-1010.
8. Reddy, J. K., and Lalwani, N. D. (1983). Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12, 1-58.
9. Reddy, J. K., Lalwani, N. D., Reddy, M. K., and Qureshi, S. A. (1982a). Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methylclofenapate and other hypolipidemic peroxisome proliferators. Cancer Res. 42, 259-266.
10. Reddy, J. K., Rao, M. S., Azarnoff, D. L., and Snell, S. (1982b). Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643), in rat and mouse liver. Cancer Res. 39, 152-161.
11. Saeter, G., Lee, C., Schwarze, P. E., Ous, S., Chen, D., Sung, J., and Seglen, P. O. (1988). Changes in ploidy distributions in human liver carcinogenesis. J. Natl. Cancer Inst. 80, 1480-1485.
12. Schulte-Hermann, R., Hoffmann, V., and Landgraf, H. (1980). Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. III. Cytological changes. Chem. - Biol. Interact. 31, 301-311.
13. Schwarze, P. E., Pettersen, E. O., Shoaib, M. C., and Seglen, P. O. (1984). Emergence of a population of small, diploid hepatocytes during hepatocarcinogenesis. Carcinogenesis 5, 1267-1275.
14. Seglen, P. O., and Gerlyng, P. (1990). Growth-related alterations during liver carcinogenesis: Effect of promoters. Environ. Health Perspect. 88, 197-205.
15. Short, J., Klein, K., Kibert, L., and Ove, P. (1980). Involvement of the iodothyronines in liver and hepatoma cell proliferation in the rat. Cancer Res. 40, 2417-2422.
16. Styles, J. A., Bybee, A., Pritchard, N. R., and Kelly, M. D. (1990). Studies on the hyperplastic response of binucleated rat hepatocytes. Carcinogenesis 11, 1149-1152.
17. Styles, J. A., Elliott, B. M., Lefevre, P. A., Robinson, M., Pritchard, N., Hart, D., and Ashby, J. (1985). Irreversible depression in the ratio of tetraploid:diploid liver nuclei in rats treated with 3′-methyl-4-dimethyl-aminoazobenzene (3′M). Carcinogenesis 6, 21-28.
18. Styles, J. A., Kelly, M., and Elcombe, C. R. (1987). A cytological comparison between regeneration, hyperplasia and early neoplasia in the rat liver. Carcinogenesis 8, 391-399.
19. Styles, J. A., Kelly, M., Pritchard, N. R., and Elcombe, C. R. (1988). A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenapate: Involvement of the binucleated hepatocytes. Carcinogenesis 9, 1647-1655.
20. Thorp, J. (1970). Hypocholesterolemic and other effects of methylclofenapate, a novel derivative of clofibrate. Atheroscler. Proc. Second Int. Symp. 541-544.
21. van Ravenzwaay, B., Tennekes, H., Stöhr, M., and Kunz, W. (1987). The kinetics of nuclear polyploidization and tumour formation in livers of CF-1 mice exposed to dieldrin. Carcinogenesis 8, 265-269.
22. Wada, N., Marsman, D. S., and Popp, J. A. (1992). Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication. Fundam. Appl. Toxicol. 18, 149-154.
23. Watanabe, M. (1970). DNA synthesis in polyploid and binucleate hepatic cells in the regenerating rat liver of different ages. Nagoya J. Med. Sci. 33, 1-11.